| Literature DB >> 27109087 |
M J Sankar1, C K Natarajan1, R R Das1, R Agarwal1, A Chandrasekaran1, V K Paul1.
Abstract
About 99% of neonatal deaths occur in low- and middle-income countries. There is a paucity of information on the exact timing of neonatal deaths in these settings. The objective of this review was to determine the timing of overall and cause-specific neonatal deaths in developing country settings. We searched MEDLINE via PubMed, Cochrane CENTRAL, WHOLIS and CABI using sensitive search strategies. Searches were limited to studies involving humans published in the last 10 years. A total of 22 studies were included in the review. Pooled results indicate that about 62% of the total neonatal deaths occurred during the first 3 days of life; the first day alone accounted for two-thirds. Almost all asphyxia-related and the majority of prematurity- and malformation-related deaths occurred in the first week of life (98%, 83% and 78%, respectively). Only one-half of sepsis-related deaths occurred in the first week while one-quarter occurred in each of the second and third to fourth weeks of life. The distribution of both overall and cause-specific mortality did not differ greatly between Asia and Africa. The first 3 days after birth account for about 30% of under-five child deaths. The first week of life accounts for most of asphyxia-, prematurity- and malformation-related mortality and one-half of sepsis-related deaths.Entities:
Mesh:
Year: 2016 PMID: 27109087 PMCID: PMC4848744 DOI: 10.1038/jp.2016.27
Source DB: PubMed Journal: J Perinatol ISSN: 0743-8346 Impact factor: 2.521
Figure 1Flow of studies.
Summary of studies that reported day-specific mortality
| Baqui | Prospective | Data from two districts of Uttar Pradesh | Neonatal deaths: 618 | Data collected by data collectors Cause of death assigned by WHO VA algorithm | Day 0: 197 (31.8%) Day 1: 48 (7.8%) Day 2: 62 (10%) Day 3: 46 (7.4%) Day 4: 25 (4%) Day 5: 28 (4.5%) Day 6: 31 (5%) Week 2: 92 (14.9%) Weeks 3–4: 89 (14.4%) | Moderate (prospective data collection) | |
| ICMR Young Infant Study Group,[ | Cross-sectional survey from January to July 2003 | Data from rural sites in five states of Uttar Pradesh | Neonatal deaths: 1521 | VA | Day 0: 598 (39.3%) Day 1: 111 (7.3%) Day 2: 155 (10.2%) Day 3: 94 (6.2%) Day 4: 84 (5.5%) Day 5: 43 (2.8%) Day 6: 43 (2.8%) Week 2: 192 (12.6%) Weeks 3–4: 199 (13.1%) | Low | |
| Chowdhury | Retrospective; 2003–2004 | Data from HDSS | Neonatal deaths: 365 | VA by interviewers Three physicians assigned the cause of death Agreement of at least two physicians required | Day 0: 136 (37.2%) Day 1: 57 (15.6%) Day 2: 56 (15.3%) Day 3: 30 (8.2%) Day 4: 8 (2.2%) Day 5: 6 (1.6%) Day 6: 6 (1.6%) Week 2: 34 (9.3%) Weeks 3–4: 32 (8.7%) | Low | Population-based data; no details on place of delivery |
| Welaga | Prospective, 2003–2009 | Data from Navrongo Health Research Centre's HDSS | Neonatal deaths: 424 | Validated VA by trained field supervisors Three physicians reviewed the VA forms and assigned cause of death Agreement of at least two physicians needed | Day 0: 119 (28%) Day 1: 55 (13%) Day 2: 21 (5%) Day 3: 30 (7%) Day 4: 17 (4%) Day 5: 21 (5%) Day 6: 17 (4%) Week 2: 64 (15%) Weeks 3–4: 85 (20%) | Moderate (prospective data collection) | Only proportion of day-wise neonatal deaths available from study (Figure 4). Actual numbers extrapolated from proportions |
| Nga | Prospective; July 2008–June 2010 | Data collected from 14 districts of Quang Ninh Province, Vietnam as part of the Knowledge into Practice for Improving Neonatal Survival (NeoKIP) project | Neonatal deaths for whom VA performed: 233 | VA using questionnaire derived from WHO Cause of death assigned by three experienced pediatricians reviewing forms independently | Day 0: 136 (57.1%) Day 1: 15 (6.4) Day 2: 14 (6%) Day 3: 6 (2.6%) Day 4: 4 (1.7%) Day 5: 6 (2.6%) Day 6: 7 (3.0%) Week 2: 24 (10.3%) Weeks 3–4: 21 (9.1%) | Moderate (prospective data collection) | |
| Belizán | Prospective; October 2009–March 2011 | Seven sites in six countries: Argentina, Guatemala, Kenya, India, Pakistan and Zambia | Neonatal deaths: 3882 | Conducted by Global Network for Women and Children's Health Research | Day 0: (2019) 52% Day 1: (427) 11% Day 2: (272) 7% Day 3: (194) 5% Day 4: (116) 3% Day 5: (78) 2% Day 6: (78) 2% Week 2: (349) 9% Week 3: (233) 6% Week 4: (116) 3% | Data extrapolated from Figure 1 in the original study | |
| Khatun | Prospective; January 2008–December 2009 | Urban slums in Bangladesh | Neonatal deaths: 260 | VA—cause of death assigned by physicians | Day 0: (94) 36% Day 1: (31) 12% Day 2: (23) 9% Day 3: (16) 6% Day 4: (8) 3% Day 5: (10) 4% Day 6: (10) 4% Week 2: (39) 15% Week 3: (17) 6.5% Week 4: (12) 4.5% | Data extrapolated from Figure 2 in the original study | |
| Campbell | Retrospective | Egypt DHS (January 1998–April 2000) | Neonatal deaths: 117 | Three methods were compared: WHO VA Revised Wigglesworth classification Consensus by two neonatologists | Day 0: 35 (29.9%) Day 1: 8 (6.8%) Day 2: 16 (13.7%) Day 3: 13 (11.1%) Day 4: 6 (5.1%) Day 5: 6 (5.1%) Day 6: 5 (4.3%) Weeks 2–4: 28 (23.9%) | Low | |
| Bang | Prospective; 1995–1996 | Rural India | Neonatal deaths: 40 | Cause of death assigned by neonatologist based on maternal and neonatal records | Day 0–2: 14 (35%) Days 3–6: 9 (22.5%) Days 8–14: 11 (27.5%) Days 15–28: 6 (15%) | Moderate (prospective data collection) | |
| Edmond | Prospective; January 2003–June 2004 | Central Ghana | Neonatal deaths: 590 | VA | Day 0: 242 (41%) Days 2–7: 195 (33.1%) Days 8–28: 153 (25.9%) | Moderate (prospective data collection) | |
| Waiswa | Prospective; January 2005–December 2008 | Iganga/Mayuge districts | Neonatal deaths: 64 | VA | Day 0: 30 (46.8%) Day 1: 8 (12.5%) Days 3–28: 26 (40.6%) | Moderate (prospective data collection) | |
| Bapat | Prospective; 2005–2007 | 48 slum settlements in Mumbai | Newborn deaths: 210 (but data only available for 116) | VA by trained field researchers Cause of death classified by clinicians | Day 0: 40 (34.5%) Day 1: 12 (10.3%) Day 2: 11 (9.5%) Days 3–6: 24 (20.7%) Weeks 2–4: 29 (25%) | Moderate (prospective data collection) | |
| Upadhyay | Cross-sectional study 2010 | Data from 28 villages under Comprehensive Rural Health Services Project | Neonatal deaths: 50 | Data collected by interviewing mothers of neonates who died during 2010 using a standardized VA tool Cause of death assigned by three investigators who reviewed forms | Day 0: 22 (44%) Days 1–6: 16 (32%) Weeks 2–4: 12 (24%) | Low | |
| Niswade | Prospective; November 2006–October 2007 | Data collected by Neonatal Disease Surveillance study in Ramtek Tehsil, Nagpur | Neonatal deaths: 36 | Data collected by study research assistants visiting mothers on days 1, 7 and 28 Active and passive surveillance systems used | Day 0: 15 (41.7%) Day 6: 11 (30.6%) Day 28: 10 (27.8%) | Moderate (prospective data collection) | |
| Rajindrajith | Retrospective | Data from registrar general's office (1997–2001) | Neonatal deaths: 17 946 | Cause of death assigned by physicians | Early neonatal death: 90.5% Death on day 1: 32% | — | |
| Gill | Prospective June 2006–November 2008 | Data from Lufwanyama district | Neonatal deaths: 100 Control group: 58 | Data collected by data collectors; helped by birth attendants Cause of death assigned by WHO VA algorithm | Neonatal deaths in control group Days 0–1: 40 (69%) Days 2–27: 18 (31%) | — | Data from the control group of cluster RCT used |
Abbreviations: DHS, Demographic and Health Survey; HDSS, health and demographic surveillance system; ICMR, Indian Council of Medical Research; RCT, randomized controlled trial; VA, verbal autopsy; WHO, World Health Organization.
Figure 2(a) Distribution of overall neonatal deaths (week-wise). (b) Distribution of neonatal deaths in the first week of life.
Summary of studies that reported cause-specific mortality by day of life
| 0 | 1 | 2 | 3 | 4 | 5 | 6 | 2 | 3–4 | |||||||
| Birth asphyxia/injury ( | 61 (70.1) | 6 (6.8) | 7 (8.0) | 3 (3.4) | 1 (1.1) | 4 (4.5) | 3 (3.4) | 2 (2.2) | 0 | ||||||
| Prematurity ( | 52 (31.3) | 18 (10.8) | 14 (8.4) | 14 (8.4) | 8 (4.8) | 7 (4.2) | 11 (6.6) | 18 (10.8) | 24 (14.4) | ||||||
| Sepsis/pneumonia ( | 16 (10.7) | 11 (7.3) | 14 (9.3) | 10 (6.7) | 8 (5.3) | 7 (4.6) | 10 (6.7) | 41 (27.5) | 32 (21.4) | ||||||
| Tetanus ( | 0 | 0 | 0 | 5 (20) | 2 (8) | 2 (8) | 0 | 10 (40) | 6 (24) | ||||||
| Diarrhea ( | 1 (10) | 0 | 0 | 0 | 0 | 0 | 2 (20) | 2 (20) | 5 (50) | ||||||
| Congenital anomaly ( | 19 (47.5) | 2 (5) | 1 (2.5) | 3 (7.5) | 2 (5) | 2 (5) | 1 (2.5) | 5 (12.5) | 5 (12.5) | ||||||
| Not identified | 48 (36.6) | 11 (8.3) | 26 (19.8) | 11 (8.3) | 4 (3) | 6 (4.5) | 4 (3) | 14 (10.6) | 7 (5.3) | ||||||
| Birth asphyxia ( | 12 (63.1) | 7 (36.8) | 0 | ||||||||||||
| Prematurity ( | 8 (50) | 0 | 8 (50) | ||||||||||||
| Sepsis/pneumonia ( | 6 (30) | 0 | 14 (70) | ||||||||||||
| Tetanus ( | 0 | 0 | 2 (100) | ||||||||||||
| Congenital defects ( | 0 | 1 (100) | 0 | ||||||||||||
| Not identified ( | 4 (66.6) | 0 | 2 (33.3) | ||||||||||||
| Birth asphyxia ( | 7 (87.5) | 1 (12.5) | 0 | 0 | |||||||||||
| Prematurity ( | 6 (100) | 0 | 0 | 0 | |||||||||||
| Sepsis/pneumonia ( | 0 | 5 (23.8) | 11 (52.3) | 5 (23.8) | |||||||||||
| Tetanus ( | 0 | 0 | 0 | 0 | |||||||||||
| Hypothermia ( | 0 | 1 (100) | 0 | 0 | |||||||||||
| Others/not known | 1 (7.1) | 2 (22.2) | 0 | 1(16.7) | |||||||||||
| Infection ( | 16 (6.7) | 91 (38.5) | 129 (54.6) | ||||||||||||
| Birth asphyxia ( | 148 (75.5) | 45 (22.9) | 3 (1.5) | ||||||||||||
| Prematurity ( | 64 (54.2) | 43 (36.4) | 11 (9.3) | ||||||||||||
| Congenital defects ( | 6 (37.5) | 9 (56.2) | 1 (6.2) | ||||||||||||
| Others ( | 4 (66.7) | 0 | 2 (33.3) | ||||||||||||
| Unexplained ( | 3 (37.5) | 3 (37.5) | 2 (25) | ||||||||||||
| Asphyxia ( | 8 (57.1) | 6 (42.8) | 0 | ||||||||||||
| Prematurity ( | 11 (78.5) | 2 (14.2) | 1 (7.14) | ||||||||||||
| Infections ( | 0 | 5 (41.6) | 7 (58.3) | ||||||||||||
| Congenital defects ( | 0 | 2 (50) | 2 (50) | ||||||||||||
| Others ( | 1 (20) | 2 (40) | 2 (40) | ||||||||||||
| Undetermined ( | 2 (50) | 0 | 2 (50) | ||||||||||||
| Birth asphyxia ( | 65 (95.5) | 2 (2.9) | 1 (1.4) | ||||||||||||
| Prematurity ( | 16 (76.1) | 5 (23.8) | 0 | ||||||||||||
| Infection ( | 16 (21.3) | 27 (36.0) | 32 (42.7) | ||||||||||||
| LBW-related ( | 6 (75) | 0 | 2 (25) | ||||||||||||
| Congenital defects ( | 1 (25) | 2 (50) | 1 (25) | ||||||||||||
| Hypothermia ( | 2 (66.7) | 1 (33.3) | 0 | ||||||||||||
| HDN ( | 0 | 1 (50) | 1 (50) | ||||||||||||
| Others ( | 1 (50) | 1(50) | 0 | ||||||||||||
| Birth asphyxia ( | 61 (77.2) | 14 (17.7) | 4 (5.1) | ||||||||||||
| Prematurity/LBW( | 58 (64.4) | 15 (16.7) | 17 (18.9) | ||||||||||||
| Infection ( | 0 (0) | 14 (45.2) | 17 (54.8) | ||||||||||||
| Congenital defects ( | 9 (56.3) | 4 (25) | 3 (18.7) | ||||||||||||
| Others/unknown ( | 8 (47.1) | 5 (29.4) | 4 (23.5) | ||||||||||||
| Infections | 37% | 63% | |||||||||||||
| Prematurity/LBW | 88% | 12% | |||||||||||||
| Birth injury | 97% | 3% | |||||||||||||
| Infanticide | 46% | 54% | |||||||||||||
| Others | 63% | 37% | |||||||||||||
| Undiagnosed | 63% | 37% | |||||||||||||
| Ngoc et al.,[ | Prospective | Data from multicenter study | Early neonatal deaths: 71 | Cause of death assigned by one of the investigators | Early neonatal deaths ( | WHO multicenter study on calcium supplementation for prevention of pre-eclampsia | |||||||||
| Asphyxia ( | 6 (85.7) | 1 (14.2) | |||||||||||||
| Prematurity/LBW ( | 11 (68.7) | 5 (31.2) | |||||||||||||
| Congenital anomaly ( | 12 (80) | 3 (20) | |||||||||||||
| Sepsis ( | 7 (70) | 3 (30) | |||||||||||||
| Others ( | 4 (50) | 4 (50) | |||||||||||||
| Asphyxia ( | 162 (98.7) | 2 (1.2) | |||||||||||||
| Prematurity/LBW ( | 76 (95) | 4 (5) | |||||||||||||
| Sepsis ( | 17 (37.7) | 28 (62.2) | |||||||||||||
| Pneumonia ( | 9 (45) | 11 (55) | |||||||||||||
| Others ( | 43 (76.7) | 13 (23.2) | |||||||||||||
| Serious infection ( | 6 (64.7) | 11 (35.2) | |||||||||||||
| Birth asphyxia ( | 21 (100) | 0 | |||||||||||||
| Prematurity ( | 8 (80) | 2 (20) | |||||||||||||
| Congenital defects ( | 2 (100) | 0 | |||||||||||||
| Diarrhea ( | 0 | 4 (100) | |||||||||||||
| Others/unknown ( | 3 (75) | 1 (25) | |||||||||||||
| Asphyxia ( | 32 (97) | 1 (3.0) | |||||||||||||
| Prematurity/LBW ( | 27 (100) | 0 (0) | |||||||||||||
| Sepsis ( | 5 (20) | 20 (80) | |||||||||||||
| Congenital anomalies ( | 5 (71.4) | 2 (28.6) | |||||||||||||
| Others/unclassified ( | 18 (75) | 6 (25) | |||||||||||||
Abbreviations: HDN, hemorrhagic disease of newborn; HDSS, health and demographic surveillance system; LBW, low birth weight; NeoKIP, Knowledge into Practice for Improving Neonatal Survival; VA, verbal autopsy; WHO, World Health Organization.
Figure 3(a) Distribution of deaths due to asphyxia. (b) Distribution of deaths due to prematurity. (c) Distribution of deaths due to sepsis. (d) Distribution of deaths due to congenital malformations.